Cargando…
In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection
Autores principales: | Cho, Hye-Kyung, Karau, Melissa J., Greenwood-Quaintance, Kerryl E., Hansford, Karl A., Cooper, Matthew A., Blaskovich, Mark A. T., Patel, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092875/ https://www.ncbi.nlm.nih.gov/pubmed/33685894 http://dx.doi.org/10.1128/AAC.02443-20 |
Ejemplares similares
-
1255. In Vitro Activity of Vancapticin against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection
por: Cho, Hye-Kyung, et al.
Publicado: (2020) -
Impact of the new membrane-targeting lipoglycopeptide antibiotic MCC5145 on the treatment of bacteremic pneumococcal pneumonia in mice
por: Ogunniyi, Abiodun D., et al.
Publicado: (2023) -
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
por: Karau, Melissa J, et al.
Publicado: (2013) -
1277. Antimicrobial Resistance in Periprosthetic Joint Infection over a Decade
por: Otero, Judith Alvarez, et al.
Publicado: (2023) -
2143. in-vitro activity of Bacteriophages against Methicillin-Resistant Staphylococcus aureus Biofilms
por: Parmar, Krupa, et al.
Publicado: (2023)